Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice.
Ruiz-Miyazawa KW, Staurengo-Ferrari L, Pinho-Ribeiro FA, Fattori V, Zaninelli TH, Badaro-Garcia S, Borghi SM, Andrade KC, Clemente-Napimoga JT, Alves-Filho JC, Cunha TM, Fraceto LF, Cunha FQ, Napimoga MH, Casagrande R, Verri WA Jr. Ruiz-Miyazawa KW, et al. Sci Rep. 2018 Sep 18;8(1):13979. doi: 10.1038/s41598-018-32334-0. Sci Rep. 2018. PMID: 30228306 Free PMC article.
The ruthenium NO donor, [Ru(bpy)2(NO)SO3](PF6), inhibits inflammatory pain: involvement of TRPV1 and cGMP/PKG/ATP-sensitive potassium channel signaling pathway.
Staurengo-Ferrari L, Mizokami SS, Silva JJ, da Silva FO, Sousa EH, da França LG, Matuoka ML, Georgetti SR, Baracat MM, Casagrande R, Pavanelli WR, Verri WA Jr. Staurengo-Ferrari L, et al. Pharmacol Biochem Behav. 2013 Apr;105:157-65. doi: 10.1016/j.pbb.2013.02.006. Epub 2013 Mar 5. Pharmacol Biochem Behav. 2013. PMID: 23470198 Free article.
The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.
Staurengo-Ferrari L, Mizokami SS, Fattori V, Silva JJ, Zanichelli PG, Georgetti SR, Baracat MM, da França LG, Pavanelli WR, Casagrande R, Verri WA Jr. Staurengo-Ferrari L, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Nov;387(11):1053-68. doi: 10.1007/s00210-014-1030-0. Epub 2014 Aug 13. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25116441
Pimaradienoic acid inhibits inflammatory pain: inhibition of NF-κB activation and cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.
Possebon MI, Mizokami SS, Carvalho TT, Zarpelon AC, Hohmann MS, Staurengo-Ferrari L, Ferraz CR, Hayashida TH, de Souza AR, Ambrosio SR, Arakawa NS, Casagrande R, Verri WA Jr. Possebon MI, et al. J Nat Prod. 2014 Nov 26;77(11):2488-96. doi: 10.1021/np500563b. Epub 2014 Nov 13. J Nat Prod. 2014. PMID: 25394199
Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB.
Ruiz-Miyazawa KW, Pinho-Ribeiro FA, Zarpelon AC, Staurengo-Ferrari L, Silva RL, Alves-Filho JC, Cunha TM, Cunha FQ, Casagrande R, Verri WA Jr. Ruiz-Miyazawa KW, et al. Chem Biol Interact. 2015 Jul 25;237:9-17. doi: 10.1016/j.cbi.2015.05.007. Epub 2015 May 14. Chem Biol Interact. 2015. PMID: 25980587 Free article.
53 results